SCHEMBL30096985

SCHEMBL30096985

Cc1ccc(S(=O)(=O)n2ccc3c(Br)cccc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 13/20 0.56
▸ PPARG P37231 1/20 0.53
▸ PPARD Q03181 1/20 0.53
▸ PPARA Q07869 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.51
▸ UBE2N P61088 1/20 0.51
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ HTT P42858 2/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ PKM P14618 1/20 0.49
▸ POLB P06746 1/20 0.47
▸ ALDH3A1 P30838 1/20 0.47
▸ NOD1 Q9Y239 1/20 0.47
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ HTR1A P08908 3/20 0.46
▸ DRD2 P14416 2/20 0.46
▸ HTR1D P28221 2/20 0.46
▸ HTR1B P28222 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505125 1.00 HTR6 (0.56) HTR6PPARGPPARDPPARAKDM4E
SCHEMBL4023676 0.89 KDM4E (0.51) HTR6PPARGPPARDPPARAKDM4E
SCHEMBL260867 0.86 HTR6 (0.68) HTR6L3MBTL1HTTMEN1KMT2A
SCHEMBL30644286 0.86 HTR6 (0.68) HTR6L3MBTL1HTTMEN1KMT2A
SCHEMBL30285388 0.85 HTR6 (0.58) HTR6PPARGPPARDPPARAKDM4E
SCHEMBL3684432 0.85 HTR6 (0.58) HTR6PPARGPPARDPPARAKDM4E
SCHEMBL11218072 0.82 HTR6 (0.59) HTR6KDM4EUBE2NL3MBTL1HTT
SCHEMBL30949526 0.82 HTR6 (0.59) HTR6KDM4EUBE2NL3MBTL1HTT
SCHEMBL10823230 0.82 HTR6 (0.56) HTR6KDM4EUBE2NL3MBTL1HTT
SCHEMBL4560894 0.82 HTR6 (0.56) HTR6KDM4EUBE2NL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4096667-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 — — EP disclosed
Send feedback